Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Note: This grant page has been archived and is very likely out of date.
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Predicted deadline: The deadline for this grant has passed

Grant amount: US $700,000 - US $1,500,000

Fields of work: Neurological Diseases & Disorders

Applicant type: For-Profit Business

Funding uses: Research

Location of project: United States

Location of residency: United States

Overview:

NOTE: This grant has a  Notice of Early Termination of PAR-21-059, and is ending early on August 9, 2023.

The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines.

This PAR assumes that

  • a candidate biomarker has already been identified,
  • detection method technology has already been developed and analytically validated, and 
  • the research and/or clinical need and potential context of use has been identified.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed August 10, 2023 and last updated August 10, 2023